Re: HDL from an Alzheimer's disease perspective
in response to
by
posted on
Jun 27, 2019 12:09PM
Bear as we now know that according to Biogen, aducanumab has failed.
Targeting Beta-amyloid plaque does not seem to be the answer as they hoped.
Koo